Combined CLEC2d Expression and CD58 Loss Mitigate Rejection of Allogeneic T Cells
Year: 2025
Type: article
Source: Journal of Immunotherapy
Institution: Beam Therapeutics (United States)
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409119107
